Online Inhibitor – papers about Inhibitor

• Chloroquine (BA1002): Workflow Parameters for Translational

  2026-05-28

  Chloroquine (N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine) supports experimental workflows investigating autophagy, malaria, and rheumatoid arthritis mechanisms. It is best suited for in vitro and preclinical studies requiring validated autophagy inhibition or Toll-like receptor modulation; not recommended for water-based solubility protocols or applications lacking lysosomal pathway involvement.

• Troglitazone as a PPARγ Agonist: Protocols for Diabetes & On

  2026-05-27

  Troglitazone enables precision-targeted modulation of PPAR signaling, opening new avenues in both type 2 diabetes research and tumor microenvironment exploration. This guide breaks down optimized workflows and troubleshooting strategies, with actionable insights from recent breakthroughs in small molecule TAM modulation.

• JXY Modulates Macrophage Polarization in Colitis-Linked CRC

  2026-05-27

  The reference study demonstrates that Jiedu Xiaozheng Yin (JXY), a traditional Chinese medicine formula, inhibits the progression of colitis-associated colorectal cancer by promoting macrophage polarization toward a tumor-suppressive M1 phenotype through the TLR4 pathway. These findings highlight the importance of innate immune modulation in colorectal cancer intervention and provide a preclinical rationale for targeting AP-1 and related signaling nodes in tumor microenvironment research.

• Efficacy of Gepotidacin vs. Nitrofurantoin in Uncomplicated

  2026-05-26

  The EAGLE-2 and EAGLE-3 trials demonstrate that gepotidacin, a novel triazaacenaphthylene antibiotic, is non-inferior—and in one trial, superior—to nitrofurantoin for treating uncomplicated urinary tract infections in females. These results highlight gepotidacin’s promise as an oral alternative with a distinct mechanism, relevant for antibiotic resistance research and clinical development.

• GCG Disrupts SARS-CoV-2 N Protein Phase Separation to Inhibi

  2026-05-26

  The referenced study uncovers that SARS-CoV-2's nucleocapsid (N) protein undergoes RNA-triggered liquid–liquid phase separation (LLPS), a critical step in viral replication. The researchers identify (-)-gallocatechin gallate (GCG) as an effective compound that disrupts this condensation process, providing a new molecular target for antiviral intervention.

• Early Pheromone Perception Drives Neurodegeneration in C. el

  2026-05-25

  Peng et al. (2023) demonstrate that pheromone exposure during early development in C. elegans directly remodels neural circuitry and accelerates neurodegeneration in adulthood. This work elucidates how environmental chemical cues, through specific neuronal and molecular pathways, can modulate neurodevelopment and proteostasis, offering new mechanistic insight into the environmental contributions to neurodegenerative disease.

• Distinct Cell Death Pathways in ALL Induced by MTAs Across C

  2026-05-25

  This study reveals how microtubule targeting agents (MTAs) induce distinct cell death mechanisms in primary acute lymphoblastic leukemia (ALL) cells, depending on whether treatment occurs during the G1 or M phases. These findings advance understanding of MTA action in cancer therapy and inform experimental approaches involving cell death and autophagy pathways.

• Amyloid Beta-peptide (25-35): Microglial Polarization & AD M

  2026-05-24

  Explore how Amyloid Beta-peptide (25-35) (human) enables advanced modeling of microglial polarization and neuroinflammation in Alzheimer's disease research. This in-depth analysis uniquely bridges peptide-induced neurotoxicity with translational insights from the FLOT1-FOSL2-EphA2 pathway.

• Trelagliptin Succinate: Mechanistic Insights to Translationa

  2026-05-23

  This thought-leadership article explores how Trelagliptin succinate (SYR-472 succinate) advances translational diabetes and metabolic research. Blending mechanistic depth with actionable protocol guidance, it contextualizes new evidence on PI3K/Akt/GLUT4 signaling, experimental strategies, and APExBIO’s product leadership. The discussion also differentiates this analysis by bridging insights from cell biology to clinical translation, surpassing standard product reviews.

• Dextromethorphan Hydrobromide: Advanced Neuroprotection Insi

  2026-05-22

  Explore the multifaceted role of Dextromethorphan hydrobromide as an NMDA receptor antagonist in neuroprotection research. This in-depth analysis bridges molecular mechanisms, protocol optimization, and translational outlook, offering fresh perspectives beyond existing guides.

• G007-LK Tankyrase 1/2 Inhibitor: Precision in Wnt/β-Catenin

  2026-05-22

  G007-LK stands out as a gold-standard tankyrase 1/2 inhibitor, enabling targeted dissection of the Wnt/β-catenin and Hippo pathways in APC-mutant colorectal and liver cancer models. Its nanomolar potency and reproducible induction of β-catenin degradation set new benchmarks for cancer pathway research and translational applications.

• Phosphoproteomic Adaptation to Chronic Cabozantinib in RCC C

  2026-05-21

  This study applies quantitative phosphoproteomics to compare acute and chronic exposure to Cabozantinib in renal cell carcinoma (RCC) cells, revealing timescale-dependent remodeling of phosphorylation networks. Key findings include persistent MET suppression and selective activation of adhesion- and MAPK-associated pathways under chronic treatment, providing a systems-level framework for future mechanistic research into kinase inhibitor adaptation.

• 3-Deazaadenosine: Precise SAH Hydrolase Inhibitor for Epigen

  2026-05-21

  3-Deazaadenosine is a potent S-adenosylhomocysteine hydrolase inhibitor, widely used in preclinical research to manipulate methylation-dependent pathways and suppress viral replication. Its efficacy against Ebola and Marburg viruses, and its role in modulating epigenetic regulation, are supported by quantitative in vitro and in vivo evidence. APExBIO provides detailed product data for standardized experimental design.

• Triiodothyronine (T3) in Metabolic Research: Protocols & Ins

  2026-05-20

  Triiodothyronine (T3) is a precision tool in modeling thyroid hormone signaling and metabolic regulation, enabling advanced studies in adipocyte biology and cellular metabolism. This article bridges cutting-edge mechanistic insights with proven experimental workflows, offering actionable troubleshooting and optimization strategies for high-impact research.

• Quercetin as a PI3K Inhibitor: Applied Workflows for Cancer

  2026-05-20

  Quercetin, a dietary flavonoid and PI3K inhibitor, empowers researchers to dissect cell death and inflammation pathways with precision. From advanced liver injury models to apoptosis assays, APExBIO’s high-purity Quercetin unlocks reproducibility and mechanistic clarity across oncology and ferroptosis studies.

14570 records 2/972 page Previous Next 12345 下5页 Last page